PARTNER WITH US At Evaxion we welcome inquiries about new potential collaborations involving antigen discovery and lead development for new vaccine targets and interest in our current cancer and infectious disease programs.
Why work/collaborate with Evaxion?
At Evaxion, we stand at the forefront of the biotechnology industry with our advanced use of artificial intelligence and machine learning technologies to model the immune system. However, our strength lies not only in our technological innovations but also in our comprehensive, multidisciplinary approach.
Our multidisciplinary team operates within state-of-the-art facilities to pioneer the design and development of personalized and precision vaccine candidates tailored to meet specific disease signatures and partners' needs.
Our robust AI prediction models are specifically trained in the fields of cancer and infectious diseases, offering a clinically validated predictive capability that sets us apart in the biotech space. This precision allows for the rapid discovery of therapeutically relevant and delivery modality agnostic vaccine targets within 24 hours, enabling us to meet a wide range of specifications and requirements.
At Evaxion, we partner at various stages
Target Discovery
At Evaxion, we leverage the unique predictive capabilities of our proprietary AI-Immunology™ platform to accelerate vaccine target discovery and selection for cancer and infectious diseases.
Clinical Responders
At Evaxion, we harness our proprietary clinical data and predictive capabilities to develop patient responder models
Partnership Inquiry
If you would like to partner with Evaxion and our AI-Immunology™ powered vaccine discovery platform or have a technology with the potential to become an immunological treatment for a disease with an unmet medical need, we look forward to hearing from you:
